Labetalol Monograph: α1/β Blockade, Severe Hypertension, Obstetric Use and Safety

Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and learning objectives Labetalol is a mixed adrenergic antagonist that blocks vascular α1 receptors and cardiac/bronchial β1 and β2 receptors. It is used orally for selected chronic hypertension regimens and intravenously…

Read Full News

Dobutamine Monograph: Inotropic Mechanism, Shock Hemodynamics and Stress Echocardiography

Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and therapeutic scope Dobutamine is a short-acting synthetic catecholamine administered by continuous IV infusion to augment myocardial contractility. Its primary β1 agonist activity is accompanied by β2 and α1 effects that…

Read Full News

Isoprenaline Monograph: β1/β2 Agonism, Bradyarrhythmia Context and Infusion Hazards

Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and correction of prior claims Isoprenaline (isoproterenol) is a synthetic nonselective β1/β2 adrenergic agonist with negligible direct α receptor activity. Historical uses included bronchodilation and cardiovascular support, but modern indications for…

Read Full News

Dobutamine: β1 Inotropy, Cardiogenic Shock Selection and Adverse Effects

Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and key distinction Dobutamine is an IV positive inotrope used for carefully selected patients with cardiac pump failure and inadequate tissue perfusion. It is not a general antihypotensive drug: improved cardiac…

Read Full News

Clonidine: Central α2 Agonism, Hypertension, ADHD and Withdrawal Precautions

Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and structure Clonidine is a centrally acting imidazoline-derived adrenergic agonist, primarily activating α2 receptors in central autonomic circuits. It reduces sympathetic outflow, heart rate and systemic vascular resistance. It is available…

Read Full News

Phenylephrine: Alpha-1 Agonism, Perioperative Hypotension and Oral Decongestant Evidence

Medical pharmacology review updated 10 November 2026. Educational material; local labeling, emergency protocols and clinical toxicology guidance take precedence in individual patient care. Clinical overview and classification Phenylephrine is a synthetic sympathomimetic with predominantly alpha-1 adrenoceptor agonist activity. Intravenous formulations raise vascular resistance and are indicated for clinically important hypotension caused primarily by vasodilation during…

Read Full News

Edrophonium: Short-Acting Acetylcholinesterase Inhibitor and Historical Myasthenia Testing

Medical pharmacology review updated 10 November 2026. Educational material; local labeling, emergency protocols and clinical toxicology guidance take precedence in individual patient care. Overview and major correction Edrophonium chloride is a synthetic short-acting, reversible acetylcholinesterase inhibitor. It is a quaternary ammonium compound; it is not ‘tetraethylammonium chloridate’, which is a different chemical entity. By transiently…

Read Full News

Bethanechol: Muscarinic Agonism, Nonobstructive Urinary Retention and Contraindications

Medical pharmacology review updated 10 November 2026. Educational material; local labeling, emergency protocols and clinical toxicology guidance take precedence in individual patient care. Overview and chemical identity Bethanechol chloride is a direct-acting, predominantly muscarinic cholinergic agonist and a carbamylated analogue of acetylcholine. The correct empirical formula for the chloride salt is C7H17ClN2O2; the original article’s…

Read Full News

Flumazenil: Benzodiazepine-Site Antagonism, Resedation and Seizure Risk

Medical pharmacology review updated 10 November 2026. Educational material; local labeling, emergency protocols and clinical toxicology guidance take precedence in individual patient care. Overview Flumazenil is a competitive antagonist at the benzodiazepine binding site of the GABA-A receptor complex. It can reverse selected benzodiazepine-induced sedation after procedures or anesthesia and may be considered for carefully…

Read Full News

Dimercaprol (BAL): Dithiol Chelation, Acute Heavy-Metal Poisoning and Peanut-Oil Precautions

Medical pharmacology review updated 10 November 2026. Educational material; local labeling, emergency protocols and clinical toxicology guidance take precedence in individual patient care. Overview and corrected chemistry Dimercaprol, historically called British anti-Lewisite (BAL), is a sulfur-containing chelator whose chemical structure is 2,3-dimercapto-1-propanol (C3H8OS2). It is not 3,3′-dithiodipropionic acid bis(2-ethylhexyl ester), as the earlier monograph incorrectly…

Read Full News